Clinical experience with linezolid in the treatment of resistant gram-positive infections (Q28363047)

scientific article

Language	Label	Description	Also known as
English	Clinical experience with linezolid in the treatment of resistant gram-positive infections	scientific article

Statements

instance of

scholarly article

0 references

title

Clinical experience with linezolid in the treatment of resistant gram-positive infections (English)

0 references

main subject

gram-positive bacteria

0 references

1 reference

S J Antony

1

0 references

E Diaz-Vasquez

series ordinal

2

0 references

C Stratton

series ordinal

3

0 references

language of work or name

English

0 references

publication date

October 2001

0 references

published in

Journal of the National Medical Association

0 references

volume

93

0 references

issue

10

0 references

page(s)

386-91

0 references

cites work

In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2594062

retrieved

20 March 2017

Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2594062

retrieved

20 March 2017

In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2594062

retrieved

29 September 2017

In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2594062

retrieved

29 September 2017

In vitro activities in new oxazolidinone antimicrobial agents against enterococci

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2594062

retrieved

29 September 2017

In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2594062

retrieved

29 September 2017

In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2594062

retrieved

29 September 2017

Activity and mechanism of action of DuP 105 and DuP 721, new oxazolidinone compounds

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2594062

retrieved

2 June 2018

Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2594062

retrieved

27 November 2018

Methicillin-resistant Staphylococcus aureus infection in a renal allograft recipient treated successfully with a novel new antimicrobial agent (linezolid): new treatment options for infections due to resistant organisms.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2594062

retrieved

27 November 2018

In vitro activity of linezolid against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2594062

retrieved

27 November 2018

Comparative in vitro and bactericidal activity of oxazolidinone antibiotics against multidrug-resistant enterococci

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11688919

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

0 references

0 references

Clinical experience with linezolid in the treatment of resistant gram-positive infections (Q28363047)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Clinical experience with linezolid in the treatment of resistant gram-positive infections (Q28363047)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search